Blood Supply Chain Simulator & Extended Blood Matching for Sickle Cell Patients

Fuente: Zenodo
Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Oyebolu, Folarin B.
Format: Recurso digital
Sprache:Englisch
Veröffentlicht: Zenodo 2025
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1866901964078448640
author Oyebolu, Folarin B.
author_facet Oyebolu, Folarin B.
contents <p>This repository contains the software implementation and source code for our paper titled <a title="Oyebolu et al. (2024)" href="https://ieeexplore.ieee.org/document/10838863" target="_blank" rel="noopener">"Optimization Of Extended Red Blood Cell Matching In Transfusion Dependent Sickle Cell Patients"</a>:</p> <blockquote> <p>F. B. Oyebolu, M. Chion, M. L. Wemelsfelder, S. Trompeter, N. Gleadall and W. J. Astle, "Optimization of Extended Red Blood Cell Matching in Transfusion Dependent Sickle Cell Patients," 2024 Winter Simulation Conference (WSC), Orlando, FL, USA, 2024, pp. 1023-1034, doi: 10.1109/WSC63780.2024.10838863.</p> </blockquote> <h1><strong>Abstract</strong></h1> <p>Blood transfusion is a life-saving treatment for people with sickle cell disorder (SCD). Presently, blood is matched manually for transfusion using incomplete red cell blood type information, to minimize the immunological incompatibility between donor and patient. We are investigating alternative approaches to blood allocation that exploit extended blood type information measured by a new genetic test shortly to be introduced by the National Health Service in England. We formulate sequential allocation decisions as a Markov decision process and study penalty-based policies for matching, which consider up to 17 blood group antigens, including policies that look ahead to future patient appointments. We tune the policy parameters of a matching rule to minimize formation of antibodies (alloimmunization) in SCD patients and estimate that a 98% reduction in alloimmunization can be achieved compared to current policies. Finally, we show that the tuned policy parameters are robust to major supply shocks.</p> <p> </p> <p><strong>Full Changelog</strong>: https://github.com/HDSci/BloodMatcher-WSC24/compare/v1.0.0...v1.1.0</p>
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_14712406
institution Zenodo
language eng
publishDate 2025
publisher Zenodo
record_format zenodo
spellingShingle Blood Supply Chain Simulator & Extended Blood Matching for Sickle Cell Patients
Oyebolu, Folarin B.
Operations Research
Simulation
Computer Simulation
<p>This repository contains the software implementation and source code for our paper titled <a title="Oyebolu et al. (2024)" href="https://ieeexplore.ieee.org/document/10838863" target="_blank" rel="noopener">"Optimization Of Extended Red Blood Cell Matching In Transfusion Dependent Sickle Cell Patients"</a>:</p> <blockquote> <p>F. B. Oyebolu, M. Chion, M. L. Wemelsfelder, S. Trompeter, N. Gleadall and W. J. Astle, "Optimization of Extended Red Blood Cell Matching in Transfusion Dependent Sickle Cell Patients," 2024 Winter Simulation Conference (WSC), Orlando, FL, USA, 2024, pp. 1023-1034, doi: 10.1109/WSC63780.2024.10838863.</p> </blockquote> <h1><strong>Abstract</strong></h1> <p>Blood transfusion is a life-saving treatment for people with sickle cell disorder (SCD). Presently, blood is matched manually for transfusion using incomplete red cell blood type information, to minimize the immunological incompatibility between donor and patient. We are investigating alternative approaches to blood allocation that exploit extended blood type information measured by a new genetic test shortly to be introduced by the National Health Service in England. We formulate sequential allocation decisions as a Markov decision process and study penalty-based policies for matching, which consider up to 17 blood group antigens, including policies that look ahead to future patient appointments. We tune the policy parameters of a matching rule to minimize formation of antibodies (alloimmunization) in SCD patients and estimate that a 98% reduction in alloimmunization can be achieved compared to current policies. Finally, we show that the tuned policy parameters are robust to major supply shocks.</p> <p> </p> <p><strong>Full Changelog</strong>: https://github.com/HDSci/BloodMatcher-WSC24/compare/v1.0.0...v1.1.0</p>
title Blood Supply Chain Simulator & Extended Blood Matching for Sickle Cell Patients
topic Operations Research
Simulation
Computer Simulation
url https://doi.org/10.5281/zenodo.14712406